Effect of n-3 fatty acids and statins on oxidative stress in statin-treated hypercholestorelemic and normocholesterolemic women

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 171-178

  Carrepeiro, Mariana Magalhães ^a   Rogero, Marcelo Macedo ^a   Bertolami, Marcelo Chiara ^b   Botelho, Patrícia Borges ^a   Castro, Natalia ^a   Castro, Inar Alves ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Atherosclerosis; EPA; Factorial; Fatty acids; Omega; Oxidative stress; Statin

Indexed keywords

CATALASE; CORN OIL; DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID PLUS DOCOSAHEXAENOIC ACID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PLACEBO; REACTIVE OXYGEN METABOLITE; SOYBEAN OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOGENESIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIOXIDANTS; CHOLESTEROL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATIVE STRESS; PLACEBOS; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 79960220800     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.12.013     Document Type: Article

References (31)

1. Rocha V.Z., Libby P. Obesity, inflammation and atherosclerosis. Nat Rev Cardiol 2009, 6:399-409.
2. Stanner S.A., Hughes J., Kelly C.N., Buttriss J. A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr 2004, 7:407-422.
3. Chan D.C., Watts G.F., Barrett P.H., Beilin L.J., Mori T.A. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem 2002, 48:877-883.
4. Jacobson T.A. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr 2008, 87:1981S-1990S.
5. Decker E.A., Alamed J., Castro I.A. Interaction between polar components and the degree of unsaturation of fatty acids on the oxidative stability of emulsions. J Am Oil Chem Soc 2010, 87:771-780.
6. Wu W.H., Lu S.C., Wang T.F., Jou H.J., Wang T.A. Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women. Eur J Clin Nutr 2006, 60:386-392.
7. Yin H., Brooks J.D., Gao L., et al. Identification of novel autoxidation products of the ω-3 fatty acid eicosapentaenoic acid in vitro and in vivo. J Biol Chem 2007, 282:29890-29901.
8. Grundt H., Nilsen D.W., Mansoor M.A., Nordøy A. Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. Eur J Clin Nutr 2003, 57:793-800.
9. Nakamura N., Hamazaki T., Ohta M., et al. Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. Int J Clin Lab Res 1999, 29:22-25.
10. Meyer B.J., Hammervold T., Rustan A.C., Howe P.R. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects. Lipids 2007, 42:109-115.
11. Friedwald W.T., Levy R.I., Fredrickson D.S. Estimations of serum low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
12. Shirai N., Suzuki H., Wada S. Direct methylation from mouse plasma and from liver and brain homogenates. Anal Biochem 2005, 343:48-53.
13. Cheng G.W., Wu H.L., Huang Y.L. Simultaneous determination of malondialdehyde and ofloxacin in plasma using an isocratic high-performance liquid chromatography/fluorescence detection system. Anal Chim Acta 2008, 616:230-234.
14. Siluk D., Oliveira R.V., Esther-Rodriguez-Rosas M., et al. A validated liquid chromatography method for the simultaneous determination of vitamins A and E in human plasma. J Pharm Biomed Anal 2007, 44:1001-1100.
15. Prior R.L., Hoang H., Gu L., et al. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORACFL)) of plasma and other biological and food samples. J Agric Food Chem 2003, 51:3273-3279.
16. Botelho P.B., Fioratti C.O., Abdalla D.S., Bertolami M.C., Castro I.A. Classification of individuals with dyslipidaemia controlled by statins according to plasma biomarkers of oxidative stress using cluster analysis. Br J Nutr 2010, 103:256-265.
17. Adzic M., Niciforovic A., Vucic V., et al. Systemic NF-(B activation in blood cells of breast cancer patients. Redox Rep 2006, 11:39-44.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. McCord J.M., Fridovich I. Superoxide dismutase enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969, 244:6049-6055.
20. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
21. Wendel A. Glutathione peroxidase. Methods Enzymol 1981, 77:325-333.
22. Executive summary of the third report of the National Cholesterol Education Program. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
23. Farzaneh-Far R., Harris W.S., Garg S., Na B., Whooley M.A. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009, 205:538-543.
24. Wang H.H., Hung T.M., Wei J., Chiang A.N. Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc Res 2004, 61:169-176.
25. Johnson F., Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 2005, 26:340-352.
26. Wassmann S., Laufs U., Muller K., et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 2002, 22:300-305.
27. Chan D.C., Watts G.F., Barrett P.H., et al. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia. Diabetes 2002, 51:2377-2386.
28. Chan D.C., Watts G.F., Mori T.A., et al. Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity. Eur J Clin Invest 2002, 32:429-436.
29. Yokoyama M., Origasa H., Matsuzaki M., et al. Japan EPA lipid intervention study (JELIS) investigators effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
30. Eussen S., Klungel O., Garssen J., et al. Support of drug therapy using functional foods and dietary. Br J Nutr 2010, 103:1260-1277.
31. Musiek E.S., Brooks J.D., Joo M., et al. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the ω-3 polyunsaturated fatty acid docosahexaenoic acid. J Biol Chem 2008, 283:19927-19935.